The Cigna Group ( CI ) Q3 2025 Earnings Call October 30, 2025 8:30 AM EDT Company Participants Ralph Giacobbe - Senior Vice President of Investor Relations David Cordani - CEO & Chair of the Board Brian Evanko - President & COO Ann Dennison - Executive VP & CFO Conference Call Participants Lisa Gill - JPMorgan Chase & Co, Research Division Justin Lake - Wolfe Research, LLC Albert Rice - UBS Inv...
Shares of Cigna Group (CI) tumbled 17% on Thursday after the health insurer warned that profit margins in its pharmacy-benefit-services division are expected to decline over the next two years. The announcement overshadowed stronger-than-expected quarterly earnings and raised concerns that industry-wide pressures are now weighing on one of the sector's most resilient players.
Cigna Group beat Wall Street estimates for third-quarter profit on Thursday, driven by strength in the company's health services unit Evernorth that houses its pharmacy benefit management business.
Total revenues for the third quarter 2025 increased 10% to $69.7 billion Shareholders' net income for the third quarter 2025 was $1.9 billion, or $6.98 per share Adjusted income from operations1 for the third quarter 2025 was $2.1 billion, or $7.83 per share Reaffirms 2025 outlook for adjusted income from operations1,2 of at least $29.60 per share2 The Cigna Group announced a new rebate-free ph...
Cigna Group is launching a new rebate-free pharmacy benefit model which aims to bring down drug costs directly at the counter.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.